Difference between revisions of "Template:SUIT-006 O2 mt PM"
From Bioblast
Beno Marija (talk | contribs) |
|||
(2 intermediate revisions by 2 users not shown) | |||
Line 10: | Line 10: | ||
|- | |- | ||
| 1PM | | 1PM | ||
| [[PM]]<sub>[[ | | [[PM]]<sub>[[LEAK respiration|''L''(n)]]</sub> | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
Line 41: | Line 41: | ||
|- | |- | ||
| 3Omy | | 3Omy | ||
| [[PM]]<sub>[[ | | [[PM]]<sub>[[LEAK respiration|''L''(Omy)]]</sub> | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
Line 48: | Line 48: | ||
*{{Template:SUIT N}} | *{{Template:SUIT N}} | ||
*{{Template:SUIT L(Omy)}} | *{{Template:SUIT L(Omy)}} | ||
*The addition of [[oligomycin]] is optional depending on the experimental question to resolve. If it is known that ''L'' | *The addition of [[oligomycin]] is optional depending on the experimental question to resolve. If it is known that ''L''(n) has the same values for ''L''(Omy) for a kind of sample and substrates, this step may be skipped. If the carrier of oligomycin (EtOH) is used instead, it is possible to evaluate whether it affects respiration. In these cases, LEAK state is not reached again. | ||
|- | |- | ||
Line 70: | Line 70: | ||
|} | |} | ||
{{Keywords: SUIT protocols}} | |||
{{ |
Latest revision as of 13:17, 25 November 2020
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M)
|
---|---|---|---|---|
1PM | PML(n) | N | CI | 1PM
|
2D | PMP | N | CI | 1PM;2D
|
2c | PMcP | N | CI | 1PM;2D;2c
|
3Omy | PML(Omy) | N | CI | 1PM;2D;2c;3Omy
|
4U | PME | N | CI | 1PM;2D;2c;3Omy;4U
|
5Ama | ROX | 1PM;2D;2c;3Omy;4U;5Ama
|
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- Main fuel substrates
- » Glutamate, G
- » Glycerophosphate, Gp
- » Malate, M
- » Octanoylcarnitine, Oct
- » Pyruvate, P
- » Succinate, S
- Main fuel substrates
- Glossary